This is an aggregated industry headline. Read the full story at FierceBiotech →
BMS expands AI footprint with Nvidia, aiming for 'most powerful AI factory in life sciences'
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according to the announcement.
By FierceBiotech
· Jul 21, 2026
· via FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Widespread misconceptions about Type 1 diabetes could be contributing to a reluctance to get screened for the …
The WeekBriefing
Medicare’s proposal to trim hospital reimbursement for specific drugs and imaging services could extend site-n…
The WeekPharmaceutical Technology ↗
BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within t…